PetMed Express prelim Q4 sales $51-53M vs $66.5M; net loss widens to $10M; delays 10-K

PETMED EXPRESS INC

Q4 net sales estimated $51.1-53.1M (down ~21% YoY); net loss $9.9-10.4M vs $5.0M prior year.
FY2025 net sales $231.6-233.6M (down ~17% YoY); FY net loss $4.5-5.0M vs $7.5M prior year.
FY net loss includes $8.7M non-cash benefit from executive departure and $6.4M deferred tax asset valuation allowance.
Cash position $54.7M with no debt as of March 31, 2025.
Company filed Form 12b-25; expects to file annual 10-K by July 1, 2025.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.